22h
Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...
Hosted on MSN11mon
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's WhyPraxis Precision Medicines, Inc. (PRAX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend ...
Stay updated on market trends for PRAX. Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate Praxis Precision Medicines' ulixacaltamide study for ...
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) have been given an average recommendation of ...
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies ...
Charles Schwab Investment Management Inc. boosted its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report ...
Wall Street expects a year-over-year increase in earnings on lower revenues when Praxis Precision Medicines, Inc. (PRAX) reports results for the quarter ended December 2024. While this widely ...
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of ...
Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback